Alan Raises $550M for Healthtech Expansion

French healthtech unicorn Alan has successfully closed a substantial Series G funding round, raising €480 million (approximately $550 million USD). This significant capital injection propels the company's valuation to €5.5 billion ($6.3 billion USD), marking a notable increase from its previous valuation. The round was spearheaded by Amsterdam-based technology investment giant Prosus, signaling its largest commitment to the health sector to date. Existing backers Teachers' Venture Growth (TVG) and Index Ventures also participated, alongside new investor Dara Holdings. The transaction awaits customary regulatory approvals, including clearance from the French financial regulator ACPR.

Founded in 2016, Alan disrupted the traditional insurance market by becoming the first newly licensed health insurer in France since the 1980s. Evolving beyond its digital-first insurance roots, the company now operates as a comprehensive health platform. Its innovative approach, termed 'prevention insurance,' shifts the focus from reactive treatment to proactive well-being. This integrated model combines insurance with preventative care and immediate access to health services, all managed through a single application.

The platform offers a suite of services including personalized prevention plans, a 24/7 virtual clinic, an online optical center, and direct physician access. Alan emphasizes speed and efficiency, boasting an average phone response time of just 20 seconds, with 99% of reimbursements processed within a day, and 70% completed in under an hour. This operational excellence contributes to consistently high customer satisfaction, reportedly above 4.2 out of 5 points.

Alan enters this new growth phase from a position of considerable financial strength. In the first quarter of 2026, the company surpassed €800 million in Annual Recurring Revenue (ARR), representing a 53% year-over-year increase. Notably, Alan has achieved profitability in its primary market, France. The company aims to exceed €1 billion in ARR by the end of the year, according to reports. With over 850 employees, Alan serves more than 1.1 million members and over 37,000 businesses, freelancers, and retirees across France, Spain, Belgium, and Canada.

A key driver for this partnership is the strategic integration of Artificial Intelligence. Alan leverages AI to deliver personalized prevention strategies and streamline navigation through complex healthcare systems. Prosus, in turn, grants Alan access to its proprietary 'Large Commerce Model' (LCM) and extensive international network, facilitating expansion into new territories. This investment also marks Prosus's strategic entry into the health sector, aligning with its broader 'Life Assistant' strategy to enhance its consumer ecosystem.

Jean-Charles Samuelian-Werve, CEO and co-founder of Alan, highlighted Prosus's expertise in international growth and consumer products as critical factors in their decision. He also noted his advisory role with French AI leader Mistral AI. Samuelian-Werve reiterated Alan's mission to transform healthcare by eliminating delays in care and prioritizing preventative measures. The newly acquired capital will fuel international expansion, potential acquisitions, and continued investment in AI, health services, and product development, with the ultimate goal of establishing its prevention-focused model as a global standard.